Research study Program year 2022 Source: CMS Open Payments

An International Phase 3 Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

ClinicalTrials.gov NCT03751124

Research payments

$462,985

211 payments

Through program year 2022, $462,985 in research payments was reported against An International Phase 3 Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids, across 211 payments, paid by Myovant Sciences Inc..

Paid by: Myovant Sciences Inc.
ClinicalTrials.gov: NCT03751124

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$16,248	6
2021	Research	$446,737	205

Breakdown

Who paid Research payments · program years 2021–2022

Myovant Sciences Inc. $462,985 211 payments

Who received the money Research payments · program years 2021–2022

Unified Women's Clinical Research Organisation paid for research $49,439 17 payments
Miami Clinical Research Lllp Organisation paid for research $42,082 7 payments
Omega Research Orlando LLC Organisation paid for research $24,590 17 payments
Cactus Clinical Research INC Organisation paid for research $21,226 5 payments
Hospital Of The Univ Of Penna Teaching hospital · PA $20,091 4 payments
Wayne State University Organisation paid for research $17,741 9 payments
Ko Clinical Research LLC Organisation paid for research $14,247 5 payments
Clinovation Research LLC Organisation paid for research $13,777 3 payments
Elias Research Associates Organisation paid for research $13,508 4 payments
Womens Healthcare Research Organisation paid for research $12,946 5 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.